Table 1 Peptides selected by OncoPeptVAC for use in T-cell activation assays.

From: Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals

Peptide ID

# Class-I HLA restriction

#Class-II HLA restriction

OncoPeptVAC score for individual HLAs (range)

Class-I binding percentile rank (range)

Class-II binding percentile rank (range)

Presence in spike peptide pools

Other features

Pep-1

3

0

0.21–0.51

0.27–0.77

NA

Yes

One contact residue for neutralizing Ab

Pep-2

0

2

NA

NA

7.6–7.8

No

4 ACE contact residues and 2 contact residues for neutralizing Ab

Pep-3

1

3

0.27

0.83

1.5–8.5

No

 

Pep-4

7

9

0.43–0.94

0.02–0.25

0.58–10.0

No

 

Pep-5

2

1

0.24–0.28

0.45–0.49

3.1

Yes

4 ACE contact residues

Pep-6

6

10

0.28–0.9

0.37–0.97

0.27–9.6

No

 

Pep-7

11

18

0.21–0.94

0.06–0.8

0.49–9.3

Yes

 

Pep-8

14

16

0.21–0.7

0.01–0.87

0.97–10.0

No

 

Pep-9

27

13

0.22–0.96

0.02–0.89

1.8–8.8

No

 

Pep-10

4

9

0.23–0.83

0.19–0.71

0.45–8.8

No

5 ACE contact residues and 2 contact residues for neutralizing Ab

Pep-11

6

2

0.22–0.88

0.44–0.9

7.2–8.0

No

Â